Sylvester Comprehensive Cancer Center

The Eight Things You Didn’t Know About Lung Cancer

11.17.2015

Lung Cancer

November is Lung Cancer Awareness Month and at Sylvester Comprehensive Cancer Center, we are celebrating the incredible achievements we have made in fighting this disease over the past years. In many cases, we have turned lung cancer into a treatable disease with significantly increased survival rates.

To highlight the recent breakthroughs, Sylvester lung cancer doctors developed a list of eight things you probably didn’t know about lung cancer.

  1. Lung cancer can occur in people who stopped smoking or have never smoked. The underlying causes are under intense investigation.
  2. Lung cancer is not one disease but a term to describe a number of rare diseases.
  3. Lung cancer frequently does not have symptoms in its early stages. That is why 60 percent of lung cancers are detected at advanced stages.
  4. Lung cancer is one of the few cancers for which immunotherapies have been approved by the FDA and are available at comprehensive cancer centers like Sylvester. Immunotherapies encourage the body’s own immune system to fight cancer cells, providing a targeted treatment that spares healthy tissue.
  5. Driven by cigarette smoking, lung cancer is still the number one cause of cancer-related death in the U.S. and Florida. It is responsible for more deaths than those caused by cancers of the colon, breast and prostate combined.
  6. Screening for lung cancer in high-risk individuals using CT technology saves lives. Studies have proven the life-saving potential of screenings for lung cancer and Sylvester has a research-based lung cancer screening program.
  7. Sylvester patients have better overall survival rates following treatment for all stages of lung cancer than other hospitals in the region. The Florida Cancer database indicates superior survival rates in lung cancer patients treated at Sylvester.
  8. Sylvester is at the forefront of lung cancer research. Certain immune system-based therapies have been developed at Sylvester and we are currently conducting clinical trials for end-stage patients.

Click here to learn more about lung cancer and treatment options at Sylvester.

E-mail a Friend